Moleculin Biotech, INC. (MBRX) — DEF 14A Filings
All DEF 14A filings from Moleculin Biotech, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Moleculin Seeks Shareholder Nod for 64.8M Warrant Issuance, Name Change
— Sep 15, 2025 Risk: high
Moleculin Biotech, Inc. (MBRX) is holding a Special Meeting on October 16, 2025, to address three key proposals. The primary proposal, the Nasdaq Proposal, seek -
Moleculin Biotech Details Executive Equity Awards 2021-2024
— Jul 8, 2025 Risk: medium
Moleculin Biotech, Inc.'s DEF 14A filing, dated July 8, 2025, primarily details executive compensation and equity award information for the fiscal years 2021 th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX